The orthopedic industry is currently undergoing a violent but necessary cleansing.
We have officially exited the "FOMO" era of easy capital and new shinny implant features.
The conference floors are crowded with them: companies—and often entire legacy product lines—that exist only because interest rates were low and hype was high.
Whether it’s a new new coating, another "me-too" SI fusion screw, or a robotic arm chasing a problem that doesn't exist, the industry has spent years burning venture dollars on "Clinical Data Theater."
But the spigot has been turned off. The market is purging "shinny new features", and in their place, a new dominant species is emerging: The Throughput Accelerator.
The Pivot: From Implants to Velocity
If you think you’re still in the business of selling titanium or polyethylene, you’re already obsolete. In the modern hospital and the rapidly expanding ASC landscape, the only currency that matters is throughput.
The "Zombie" mindset is product-obsessed. The "Accelerator" mindset is process-obsessed. The market is finally forcing us to work on real problems, and the most critical question for any strategy today is:
Are you increasing or decreasing the ...
